SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-22-012442
Filing Date
2022-07-05
Accepted
2022-07-05 07:35:25
Documents
12
Period of Report
2022-07-05
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K dyn-20220705.htm   iXBRL 8-K 63532
  Complete submission text file 0000950170-22-012442.txt   188823

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT dyn-20220705.xsd EX-101.SCH 2468
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT dyn-20220705_lab.xml EX-101.LAB 17762
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT dyn-20220705_pre.xml EX-101.PRE 11056
6 EXTRACTED XBRL INSTANCE DOCUMENT dyn-20220705_htm.xml XML 4697
Mailing Address 1560 TRAPELO ROAD WALTHAM MA 02451
Business Address 1560 TRAPELO ROAD WALTHAM MA 02451 (781) 786-8230
Dyne Therapeutics, Inc. (Filer) CIK: 0001818794 (see all company filings)

IRS No.: 364883909 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39509 | Film No.: 221063202
SIC: 2834 Pharmaceutical Preparations